Wednesday

Keynote II Scott Gottlieb, MD

Washington is heading into a period of turnover, and federal health agencies will need to strengthen their workforce and regulatory approaches to keep pace with fast-moving innovation, former FDA Commissioner Scott Gottlieb, MD, said Tuesday during ASTRO’s second Keynote of the Annual Meeting.

Neurocognitive outcomes following SRS

Chia-Lin Tseng, MD, Sunnybrook Odette Cancer Center, Toronto, Canada, presented neurocognitive outcomes in patients with 5-50 brain metastases treated with stereotactic radiosurgery (SRS) in a phase II single arm clinical trial.

Do conventional cardiac DVH predictors still generalize to contemporary radiotherapy practice?

Improving cardiac event prediction for patients with Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) is possible by leveraging the ability of medical foundation models to provide alternative representations of medical images.

Identifying avenues to utilize AI and large language models to their full potential

Incident learning platforms are powerful tools that can help us ensure efficient and safe delivery of treatment through lessons learned.

HEADLIGHT lights a path to hypofractionation in head and neck squamous cell carcinoma

Hypofractionated radiotherapy regimens developed over the past two decades have substantially improved access to curative therapy for several common malignancies, most notably those of the prostate and breast.

Long-term results in recurrent glioblastoma

Maciej Harat, MD, PhD, and colleagues presented long term results from their prospective phase II trial, TTaRGeT, combining tumor treating fields (TTF) and 18F-FET PET-guided stereotactic radiosurgery (SRS) in recurrent IDH wild-type GBM.

2026 Survivor Circle Grants awarded Sunday

On Sunday, ASTRO awarded this year’s recipients, Boston Medical Center Corporation and Love Bus, with Survivor Circle Grants of $12,500 each.

A Dose of Art: The Art, Poetry, and Humanity of The Red Journal and Radiation Oncology

This special session informed attendees about the opportunities for publishing their art on the cover of the Red Journal and publish their poetry in the journal’s “A Dose of Poetry” section, as well as helping cultivate the arts in the field of radiation oncology.

New research sharpens the picture of fracture risk after spine SBRT, though prevention remains elusive

Three studies presented at ASTRO 2026 in Boston are advancing the field's understanding of vertebral compression fracture (VCF), a consequential potential side effect from stereotactic body radiation therapy (SBRT) of spinal metastases.